Hints and tips:
Related Special Reports
...Ogilvy, which has previously worked with a host of pharma groups including Pfizer and Johnson & Johnson, is launching a business that offers vetted influencers to talk about illnesses and possible solutions...
...He said its products complied with the EU’s “extremely strict” production standards and that its factories were comparable “to the Pfizers of the world”....
...Meanwhile, medical devices company Smith & Nephew wants to increase pay for its US executives to bring it closer to American levels....
...While some investors are sceptical of companies without long-term growth plans, she said Moderna had met every challenge....
...It’s a drug that’s active against [resistant] pathogens that gives us a tool to treat the type of infection that we don’t have good options for now,” said Jay Purdy, Pfizer’s vice-president of global medical...
...The US government arranged with Pfizer to return 7.9mn Paxlovid courses at the end of 2023, at an estimated cost to the company of $4.2bn....
...The medical tourism component was “creative”, he added, emphasising that the key was to make “a live rhino worth more than a dead rhino”....
...GSK secured approval for Arexvy from the US Food and Drug Administration at the start of May, almost a month before Pfizer’s Abrysvo....
...Pfizer’s efforts to develop an obesity pill have suffered setbacks. It has abandoned plans for two treatments already....
...Pfizer is abandoning its plans for a weight loss pill to be taken twice a day after trials showed it caused significant side effects, in a setback to the US drugmaker’s effort to enter the fast-growing market...
...To make up for the shortfall in its pipeline, the US drugmaker earlier this year announced plans to buy Seagen, an oncology drugmaker, for $43bn; a deal Pfizer said it expected to close on Thursday....
...BlackRock’s offices have also been targeted for periodic protests by climate activists who say it has not done enough to promote decarbonisation.In 2022, the asset manager set up personal security plans...
...There have been large investments in vaccine delivery systems in recent years, such as the mRNA technology used for the BioNTech/Pfizer and Moderna Covid-19 vaccines....
...Last week, Pfizer slashed its 2024 revenue outlook and increased its cost-cutting programme by $500mn....
...The US federal drug regulator has approved new Covid-19 boosters from Moderna and Pfizer, as it moves to contain infections from spreading more quickly in the US....
...In March, officials from 194 countries came together to agree on a global plan to deal with a threat known as “Disease X”....
...The Centers for Medicare & Medicaid Services said last month that Medicare Part D drug benefit plans will cover weight loss medicines when they are approved to treat a separate medical problem, such as heart...
...Moderna alleges that Pfizer and BioNTech infringed on two of its patents in their use of the critical mRNA platform. BioNTech and Pfizer say the patents are invalid....
...“The biggest barrier is insurance companies,” said Lawrence Honig, a neurologist at New York’s Columbia University Irving Medical Center....
...Yet Netanyahu has presented no clear plan about who will administer Gaza or maintain civil order. Still, the IDF insists the battle at al-Shifa represents its war plan in action....
...Yet Pfizer’s $19bn in Paxlovid sales were almost a fifth of its 2022 total....
...“We will set out a full implementation plan following careful consideration of this final report and its recommendations,” said NHS England....
...Haleon was born as a joint venture between Pfizer and GSK in 2019 that sat within GSK, before it was spun off via a UK listing in 2022, leaving GSK and Pfizer with 13.5 per cent and 32 per cent of the business...
...Germany’s BioNTech, which developed its own mRNA-based Covid vaccine with Pfizer, has also scaled back its African ambitions but has broken ground on a vaccine manufacturing site in Rwanda....
...If it succeeds in a phase-3 trial, the vaccine candidate, dubbed IVX-A12, would compete with approved RSV shots from GSK and Pfizer, and potentially one from Moderna....
International Edition